A Phase 2, Open-label Trial of Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Latest Information Update: 25 Sep 2021
At a glance
- Drugs Nivolumab (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 07 Jun 2021 New trial record